Home / Compare / Semaglutide vs Tirzepatide

Semaglutide vs Tirzepatide

The two leading GLP-1 metabolic peptides behind the weight-loss wave. Here's a neutral, sourced side-by-side — no hype, every claim links to its evidence.

By The Health Stacks Research Team

Semaglutide

Approved

Also: Ozempic, Rybelsus

Semaglutide is a special medicine that acts like a natural hormone in the body to help control blood sugar and weight. Studies show it can also help the heart and liver work better.While semaglutide helps many people, it does not work for every health issue.

533 studies1504 benefits documented
Where to Source Semaglutide

Tirzepatide

Research

Also: Mounjaro, Zepbound

Tirzepatide is a special medicine that acts like two different hormones in the body at the same time. It is often used by people who need help managing their weight or blood sugar levels.

310 studies687 benefits documented
Where to Source Tirzepatide

At a Glance

SemaglutideTirzepatide
Research statusApprovedPreclinical
Benefits documented1504687
Research citations533310
Dosing routesSubcutaneousSubcutaneous
Known side effects764334

What Each Helps With

Top documented benefits — backed by research.

Semaglutide

  • Weight loss (~15%)
  • Glycemic control
  • Cardiometabolic improvement

Tirzepatide

  • Weight loss (~20.9%)
  • Glycemic control
  • Superior to semaglutide 1 mg

How People Use It

Reported protocols — research only, not medical advice.

Semaglutide

  • 2400 mcg, subcutaneous — Chronic weight management (BMI >=30, or >=27 with comorbidity)
  • subcutaneous — Subcutaneous injection
  • subcutaneous — 0.25mg to 2.4mg weekly
  • subcutaneous — 0.25mg (250mcg) weekly

Tirzepatide

  • 15000 mcg, subcutaneous — Chronic weight management / type 2 diabetes
  • subcutaneous — Up to 15 mg
  • subcutaneous — Once weekly
  • subcutaneous — 1.8 mg daily

The Evidence

Key studies — click through to verify each on PubMed.

Semaglutide

533 sourced studies

  • Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1)

    RCT2021 Key study 95/100
    Source
  • Two-Year Effects of Semaglutide (STEP 5)

    RCT2022 92/100
    Source
  • Once-Weekly Semaglutide for Weight Management: A Clinical Review

    Review2022 82/100
    Source
  • STEP 1 - Semaglutide in Overweight/Obesity

    Registry2018 88/100
    Source

Tirzepatide

310 sourced studies

  • Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)

    RCT2022 Key study 95/100
    Source
  • SURPASS-1: Efficacy and Safety of a Novel Dual GIP/GLP-1 Receptor Agonist

    RCT2021 93/100
    Source
  • Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction.

    MetaAnalysis2022 88/100
    Source
  • Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes

    Source

How to Choose

Neither is a “winner” — they suit different goals. Compare the documented benefits and evidence above against what you’re actually trying to achieve, note the research status (approved vs research-stage), and read each full guide before deciding. Many people also stack peptides rather than pick one.

Source Semaglutide

Find Semaglutide Suppliers
Tested purity COA available Fast shipping

Source Tirzepatide

Find Tirzepatide Suppliers
Tested purity COA available Fast shipping
Educational content only. Peptides discussed are generally research compounds, not FDA-approved for human use unless stated. Consult a healthcare professional before use.